Reinberg A, Lévi F
Fondation Adolphe de Rothschild, Paris, France.
Scand J Rheumatol Suppl. 1987;65:118-22. doi: 10.3109/03009748709102189.
Both drug disposition and effects vary as a function of dosing time. A chronotherapeutic study was therefore undertaken with sustained-release indomethacin (ISR) to quantitate any potential therapeutic gain from an optimal time of administration. Four studies were performed on a total of 517 patients with osteoarthritis of the hip or knee. Each patient took the same dose of ISR at 8:00 am for one week, 12:00 noon for one week and 8:00 pm for one week. In addition to conventional evaluation criteria, patients performed self-rating of pain on visual analogue scales. Overall, there were 44 withdrawals (29 associated with morning ingestion). At group level, time-dependent differences in drug effectiveness were small, although large inter-individual differences were documented. Evening ingestion was most effective in patients with predominant nocturnal or morning pain; conversely, morning or noon ingestion was most effective in patients with maximum afternoon or evening pain. A four-fold improvement in tolerance and a doubling of analgesic effectiveness resulted from varying the ingestion time. Chronotherapeutic studies should therefore include careful longitudinal documentation of pertinent marker rhythms such as self-rating of pain.
药物处置和效应均随给药时间而变化。因此,开展了一项关于缓释吲哚美辛(ISR)的时间治疗学研究,以量化最佳给药时间可能带来的治疗益处。对总共517例髋部或膝部骨关节炎患者进行了四项研究。每位患者在上午8点服用相同剂量的ISR,持续一周;在中午12点服用相同剂量的ISR,持续一周;在晚上8点服用相同剂量的ISR,持续一周。除了常规评估标准外,患者还通过视觉模拟量表对疼痛进行自我评分。总体而言,共有44例患者退出研究(其中29例与早晨服药有关)。在组水平上,尽管记录到个体间存在较大差异,但药物疗效的时间依赖性差异较小。对于主要在夜间或早晨疼痛的患者,晚上服药最为有效;相反,对于下午或晚上疼痛最严重的患者,早晨或中午服药最为有效。改变服药时间使耐受性提高了四倍,镇痛效果提高了一倍。因此,时间治疗学研究应包括对相关标记节律(如疼痛自我评分)进行仔细的纵向记录。